Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jun 07, 2024 |
ordered to third reading rules cal.575 rules report cal.575 reported |
May 22, 2024 |
reported referred to rules |
Mar 20, 2024 |
referred to insurance |
Assembly Bill A9539
2023-2024 Legislative Session
Sponsored By
EICHENSTEIN
Current Bill Status - On Floor Calendar
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
co-Sponsors
David Weprin
Emily Gallagher
2023-A9539 (ACTIVE) - Details
- See Senate Version of this Bill:
- S8957
- Law Section:
- Insurance Law
- Laws Affected:
- Amd §§3216, 3221 & 4303, Ins L; add §4406-j, Pub Health L
2023-A9539 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 9539 I N A S S E M B L Y March 20, 2024 ___________ Introduced by M. of A. EICHENSTEIN -- read once and referred to the Committee on Insurance AN ACT to amend the insurance law and the public health law, in relation to providing insurance coverage for rare diseases, life-threatening conditions or diseases, degenerative and disabling conditions, or diagnoses involving medically fragile children THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 39 to read as follows: (39) (A) EVERY POLICY WHICH PROVIDES HOSPITAL, SURGICAL, MEDICAL OR MAJOR MEDICAL COVERAGE SHALL PROVIDE COVERAGE FOR MEDICALLY NECESSARY SERVICES FROM A CHOSEN PROVIDER FOR A CONFIRMED DIAGNOSIS THAT IS DEEMED TO BE A RARE DISEASE, LIFE-THREATENING CONDITION OR DISEASE, DEGENERA- TIVE AND DISABLING CONDITION, OR INVOLVES A MEDICALLY FRAGILE CHILD, WITH NO RESTRICTION TO A PLAN NETWORK, IF THE FOLLOWING CONDITIONS ARE MET: (I) (A) THE COSTS OF THE CHOSEN PROVIDER ARE EQUAL TO OR LESS THAN THE AVERAGE COST THAT WOULD HAVE OTHERWISE BEEN PAID TO A LOCAL NETWORK PROVIDER WHO POSSESSES A SIMILAR SUBSPECIALTY AS SUCH CHOSEN PROVIDER; AND (B) THE PATIENT'S TREATING SPECIALIST OR PRIMARY CARE PROVIDER PROVIDES A WRITTEN STATEMENT TO RECOMMEND THE CHOSEN PROVIDER FOR THE PARTICULAR DISEASE. (II) THE CHOSEN PROVIDER OR THE PATIENT'S PRIMARY CARE PHYSICIAN PROVIDES ADVANCE NOTICE TO SUCH PATIENT'S NETWORK PLAN PRIOR TO A PLANNED PROCEDURE COVERED PURSUANT TO THIS PARAGRAPH. (III) THE CHOSEN PROVIDER IS ACCREDITED OR DESIGNATED BY THE DEPART- MENT OF HEALTH, THE FEDERAL GOVERNMENT, OR A VOLUNTARY NATIONAL HEALTH ORGANIZATION AS HAVING SPECIAL EXPERTISE IN TREATING, OR HAS DEMON- STRATED A CLINICAL FOCUS IN THE AREA OF, THE CONFIRMED DIAGNOSIS FOR WHICH COVERAGE IS SOUGHT PURSUANT TO THIS PARAGRAPH. PROVIDED HOWEVER, THAT NOTHING IN THIS PARAGRAPH SHALL REQUIRE SUCH CHOSEN PROVIDER TO BE PARTICIPATING IN THE PATIENT'S NETWORK OR LOCATED WITHIN THE STATE; EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.